Cercar
01/09/2025
Genetic Polymorphisms in Psoriasis: Investigating Genetic Variations for Precise Profiling of Response to Brodalumab in Real-Life Clinical Practice
Butrón-Bris, B, Llamas-Velasco, M, Armesto, S, Sahuquillo-Torralba, A, Pujol-Montcusi, J, Ruiz-Villaverde, R, Martinez-López, A, de la Cueva, P, Romero-Mate, A, Roustan, G, Vilarrasa-Rull, E, Ferrán-Farres, M, Ovejero-Benito, MC, Palomar-Moreno, C, Navares, M, Novalbos, J, Abad-Santos, F, Dauden, E, de la Fuente, H. Genetic Polymorphisms in Psoriasis: Investigating Genetic Variations for Precise Profiling of Response to Brodalumab in Real-Life Clinical Practice. Actas Dermo-Sifiliograficas. 2025; 116(8)DOI:10.1016/j.ad.2025.03.030. PMID:40246146. IF:(Q/D).
01/09/2025
European Guideline (EuroGuiDerm) on atopic eczema: Living update
Wollenberg, A, Kinberger, M, Arents, B, Aszodi, N, Barbarot, S, Bieber, T, Brough, HA, Calzavara-Pinton, P, Christen-Zaech, S, Deleuran, M, Dittmann, M, Fosse, N, Gáspár, K, Gerbens, LAA, Gieler, U, Girolomoni, G, Gregoriou, S, Holland, S, Mortz, CG, Nast, A, Nygaard, U, Rehbinder, EM, Ring, J, Rossi, M, Serra-Baldrich, E, Simon, D, Szalai, ZZ, Szepietowski, JC, Torrelo, A, Werfel, T, Werner, RN, Flohr, C. European Guideline (EuroGuiDerm) on atopic eczema: Living update. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2025; 39(9)DOI:10.1111/jdv.20639. PMID:40317496. IF:8.000(Q1/1D).
01/09/2025
Bimekizumab efficacy in patients with plaque psoriasis: A post hoc stratification by weight over 4 years in BE BRIGHT
Gkini, MA, López-Ferrer, A, Magnolo, N, Soung, J, Trafford, A, Pousa, ID, Kavanagh, S, Gooderham, M. Bimekizumab efficacy in patients with plaque psoriasis: A post hoc stratification by weight over 4 years in BE BRIGHT. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2025; 93(3)DOI:. PMID:. IF:11.800(Q1/1D).
01/09/2025
Bimekizumab durability of efficacy through 196 weeks and safety through 4 years in patients with moderate to severe plaque psoriasis: Results from the BE BRIGHT open-label extension trial
Blauvelt, A, Langley, RG, Lebwohl, M, Strober, B, Warren, RB, Puig, L, Morita, A, Gordon, KB, Fernandez-Peña, P, Kavanagh, S, Pinto, JML, Lambert, J, Hoepken, B, Deherder, D, Cross, N, Thaçi, D. Bimekizumab durability of efficacy through 196 weeks and safety through 4 years in patients with moderate to severe plaque psoriasis: Results from the BE BRIGHT open-label extension trial. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2025; 93(3)DOI:10.1016/j.jaad.2025.04.038. PMID:40286813. IF:11.800(Q1/1D).
22/08/2025
Transcriptomic Identification of Immune-Related Hubs as Candidate Predictor Biomarkers of Therapeutic Response in Psoriasis
Cantó, E, del Prado, ME, Vilarrasa, E, López-Ferrer, A, de Aranibar, FJGL, Ortiz, MA, Gut, M, Mulet, M, Esteve-Codina, A, Osuna-Gómez, R, Guinart-Cuadra, A, Puig, L, Vidal, S. Transcriptomic Identification of Immune-Related Hubs as Candidate Predictor Biomarkers of Therapeutic Response in Psoriasis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(17)DOI:10.3390/ijms26178118. PMID:40943056. IF:4.900(Q1/3D).
01/07/2025
Updated Perspective from the Spanish Psoriasis Working Group (GPS) on Biosimilar Drug Use in Moderate-to-Severe Psoriasis
Salgado-Boquete, L, Puig, L, Carrascosa, JM, de la Cueva, P, Ferrer, AL. Updated Perspective from the Spanish Psoriasis Working Group (GPS) on Biosimilar Drug Use in Moderate-to-Severe Psoriasis. Actas Dermo-Sifiliograficas. 2025; 116(7)DOI:10.1016/j.ad.2025.05.011. PMID:40446921. IF:(Q/D).
01/07/2025
Patient Burden and Impact of Moderate-to-Severe Atopic Dermatitis in the Spanish Healthcare System: The APOLO Cross-Sectional Study
Dobao, PD, Barredo, LC, Salvador, JFS, Serra-Baldrich, E, Pinto, PH, Cano, NH, De Frutos, FJO, Gullón, GR, Belloso, RML, Ortega, IA, Quesada, AG, Gutiérrez, MG, Calzada, YG, Torredemer, DA, Felius, NL, Martin, IH, Laserna, FJR. Patient Burden and Impact of Moderate-to-Severe Atopic Dermatitis in the Spanish Healthcare System: The APOLO Cross-Sectional Study. Dermatology Practical & Conceptual. 2025; 15(3)DOI:10.5826/dpc.1503a5538. PMID:40790435. IF:2.300(Q2/5D).
03/06/2025
The 'totality of evidence' and 'extrapolation' of SB17, a ustekinumab biosimilar
Cheon, JH, Ye, BD, Armuzzi, A, Rieder, F, Girolomoni, G, Puig, L, Jung, HJ, Feldman, SR. The 'totality of evidence' and 'extrapolation' of SB17, a ustekinumab biosimilar. EXPERT OPINION ON BIOLOGICAL THERAPY. 2025; 25(6)DOI:10.1080/14712598.2025.2508838. PMID:40396611. IF:4.000(Q2/3D).
01/06/2025
Current Challenges in Dermatology Residency Training
Ferrer, AL. Current Challenges in Dermatology Residency Training. Actas Dermo-Sifiliograficas. 2025; 116(6)DOI:10.1016/j.ad.2025.03.021. PMID:. IF:(Q/D).
01/05/2025
Acral Melanoma in the Caucasian Population: A Comprehensive Cohort Study on Epidemiological, Clinicopathological, and Prognostic Features
Angel-Baldo, J, Podlipnik, S, Azón, A, Boada, A, Arrieta, A, Marcoval, J, López-Sánchez, C, Sàbat , M, Segura, S, Bodet, D, Sabat, M, Curcó, N, Lopez-Castillo, D, Solà, J, Quintana-Codina, M, Baliu-Piqué, C, Martin-Sala, S, Just-Sarobé, M, Martín-Sala, S, Malvehy, J, Puig, S, Carrera, C, Marti, RM. Acral Melanoma in the Caucasian Population: A Comprehensive Cohort Study on Epidemiological, Clinicopathological, and Prognostic Features. Actas Dermo-Sifiliograficas. 2025; 116(5)DOI:10.1016/j.ad.2024.10.060. PMID:39798598. IF:(Q/D).
01/04/2025
RW effectiveness of tralokinumab in adults with atopic dermatitis on the genitals: Interim data on improvements in physician-assessed disease severity and PRO in up to 3 months of treatment (TRACE)
Serra-Baldrich, E, Armstrong, AW, Festini, T, Ivens, U, Nielsen, IV, Wiseman, M, Krüger-Szabo, A. RW effectiveness of tralokinumab in adults with atopic dermatitis on the genitals: Interim data on improvements in physician-assessed disease severity and PRO in up to 3 months of treatment (TRACE). JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2025; 23DOI:. PMID:. IF:3.800(Q1/2D).
01/04/2025
Anterior Thoracic Trichilemmal Carcinoma: A Rare Case with a Novel Treatment
Escanilla, C, Schroder, C, Garrido, V, Balague, M, Ruiz, V, Toscas, JI, Cevallos, C. Anterior Thoracic Trichilemmal Carcinoma: A Rare Case with a Novel Treatment. REVISTA MEDICA DE CHILE. 2025; 153(4)DOI:10.4067/s0034-98872025000400310. PMID:40493479. IF:0.300(Q4/8D).
01/04/2025
Clin. eff. & PROs in mod.-sev. AD pts treated w/ oral systemics: 12-wk interim results from AD-REAL focusing on pts w/ BSA 7 ('itch dominant')
Augustin, M, Serra-Baldrich, E, Seneschal, J, Elrayes, M, Otero-Asman, JR, Berkery, E, Fakouri, W, Bewley, A, Garcia-Latasa, J, Pinter, A, Schlöbe, A. Clin. eff. & PROs in mod.-sev. AD pts treated w/ oral systemics: 12-wk interim results from AD-REAL focusing on pts w/ BSA 7 ('itch dominant'). JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2025; 23DOI:. PMID:. IF:3.800(Q1/2D).
01/04/2025
RWeffectiveness of tralokinumab in adults with atopic dermatitis on the genitals: Interim data on improvements in physician-assessed disease severity and PRO in up to 3 months of treatment ( TRACE)
Serra-Baldrich, E, Armstrong, AW, Festini, T, Ivens, U, Nielsen, IV, Wiseman, M, Krüger-Szabo, A. RWeffectiveness of tralokinumab in adults with atopic dermatitis on the genitals: Interim data on improvements in physician-assessed disease severity and PRO in up to 3 months of treatment ( TRACE). JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2025; 23DOI:. PMID:. IF:3.800(Q1/2D).
01/04/2025
Clin. eff. & PROs inmod.-sev. AD pts treated w/ oral systemics: 12-wk interim results from AD-REAL focusing on pts w/ BSA 7 ('itch dominant')
Augustin, M, Serra-Baldrich, E, Seneschal, J, Elrayes, M, Otero-Asman, JR, Berkery, E, Fakouri, W, Bewley, A, García-Latasa, J, Pinter, A, Schlöbe, A. Clin. eff. & PROs inmod.-sev. AD pts treated w/ oral systemics: 12-wk interim results from AD-REAL focusing on pts w/ BSA 7 ('itch dominant'). JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2025; 23DOI:. PMID:. IF:3.800(Q1/2D).
01/01/2025
MEAN ABSOLUTE EASI AND PRURITUS ACHIEVED BY LEBRIKIZUMAB OVER 16 WEEKS IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
Vestergaard, C, Thaci, D, Puig, L, Papp, KA, Gold, LS, Peñas, PF, Huan, YH, Dossenbach, M, Falques, M, Agell, H, Du Jardin, KG. MEAN ABSOLUTE EASI AND PRURITUS ACHIEVED BY LEBRIKIZUMAB OVER 16 WEEKS IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS. ACTA DERMATO-VENEREOLOGICA. 2025; 105DOI:. PMID:. IF:3.700(Q1/2D).
01/01/2025
Predictive Factors and Optimization of Omalizumab in Chronic Spontaneous Urticaria: A Multicenter Study of 257 Patients
Ceravalls, J, Gímenez-Arnau, AM, Expósito-Serrano,, Chico, NF, Moya, AL, Bielsa,, Ribó, P, Mascaro-Hereza, B, Bonfill-Orti, M, Spertino, J, Serra, E, Baliu-Pique, C, Mele-Ninot, G. Predictive Factors and Optimization of Omalizumab in Chronic Spontaneous Urticaria: A Multicenter Study of 257 Patients. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2025; 35(3)DOI:10.18176/jiaci.1053. PMID:39950575. IF:4.800(Q1/1D).
01/06/2024
Italian S3-Guideline on the treatment of Atopic Eczema - Part 2: non-systemic treatments and treatment recommendations for special AE patient populations, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA).
Argenziano G, Cusano F, Corazza M, Amato S, Amerio P, Naldi L, Patruno C, Pigatto PD, Quaglino P, Gisondi P, Chiricozzi A, Tonon F, Stingeni L, Calzavara-Pinton P, Wollenberg A, Kinberger M, Arents BW, Aszodi N, Avila Valle GL, Barbarot S, Bieber T, Brough HA, Christen-Zäch S, Deleuran M, Dittmann M, Dressler C, Fink-Wagner AH, Fosse N, Gáspár K, Gerbens LA, Gieler U, Girolomoni G, Gregoriou S, Mortz CG, Nast A, Nygaard U, Redding M, Rehbinder EM, Ring J, Rossi M, Serra-Baldrich E, Simon D, Szala I ZZ, Szepietowski JC, Torrelo A, Werfel T, Flohr C. Italian S3-Guideline on the treatment of Atopic Eczema - Part 2: non-systemic treatments and treatment recommendations for special AE patient populations, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA).. Italian Journal of Dermatology and Venereology. 2024; 159(3)DOI:10.23736/S2784-8671.24.07666-7. PMID:38727634. IF:(Q/D).
31/05/2024
[Translated article] Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC).
Navarro-Triviño FJ, Borrego L, Silvestre-Salvador JF, Mercader-García P, Giménez-Arnau AM, Ortiz-de Frutos FJ, Sanz-Sánchez T, Melé-Ninot G, Sánchez-Gilo A, Zaragoza-Ninet V, Serra-Baldrich E, Miquel-Miquel J, Córdoba-Guijarro S, Rodríguez-Serna M, Ruíz-González I, Carrascosa-Carrillo JM, Gómez-de la Fuente E, Pastor-Nieto MA, Heras-Mendaza F, González-Pérez R, Sánchez-Pedreño Guillén P, Sánchez-Pérez J, Gatica-Ortega ME, Fernández-Redondo V, Hervella-Garcés M, Manrique-Martínez P, Guimaraens-Juanena D, García-Gavín J, Giménez-Arnau E, Figueras-Nart I, Curto-Barredo L, Armario-Hita JC. [Translated article] Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC).. Actas Dermo-Sifiliograficas. 2024; 115(7)DOI:10.1016/j.ad.2024.05.018. PMID:38823769. IF:(Q/D).
09/01/2024
Tofacitinib Use in the Treatment of Plantar Erosive Lichen Planus.
Mateu-Arrom L, Garcia-Muret MP, Conforto GC, Puig L. Tofacitinib Use in the Treatment of Plantar Erosive Lichen Planus.. INDIAN JOURNAL OF DERMATOLOGY. 2024; 68(6)DOI:10.4103/ijd.ijd_512_23. PMID:38371534. IF:(Q/D).
25/04/2023
Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery An International Randomized Controlled Trial
Marcucci, M, Painter, TW, Conen, D, Lomivorotov, V, Sessler, DI, Chan, MTV, Borges, FK, Leslie, K, Duceppe, E, Martinez-Zapata, MJ, Wang, CY, Xavier, D, Ofori, SN, Wang, MK, Efremov, S, Landoni, G, Kleinlugtenbelt, YV, Szczeklik, W, Schmartz, D, Garg, AX, Short, TG, Wittmann, M, Meyhoff, CS, Amir, M, Torres, D, Patel, A, Ruetzler, K, Parlow, JL, Tandon, V, Fleischmann, E, Polanczyk, CA, Lamy, A, Jayaram, R, Astrakov, SV, Wu, WKK, Cheong, CC, Ayad, S, Kirov, M, de Nadal, M, Likhvantsev, VV, Paniagua, P, Aguado, HJ, Maheshwari, K, Whitlock, RP, McGillion, MH, Vincent, J, Copland, I, Balasubramanian, K, Biccard, BM, Srinathan, S, Ismoilov, S, Pettit, S, Stillo, D, Kurz, A, Belley-Cote, EP, Spence, J, McIntyre, WF, Bangdiwala, SI, Guyatt, G, Yusuf, S, Devereaux, PJ. Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery An International Randomized Controlled Trial. ANNALS OF INTERNAL MEDICINE. 2023; 176(5)DOI:10.7326/M22-3157. PMID:37094336. IF:19.600(Q1/1D).
10/02/2023
Myocardial injury after major non-cardiac surgery evaluated with advanced cardiac imaging: a pilot study
Álvarez-Garcia J., Popova E., Vives-Borrás M., de Nadal M., Ordonez-Llanos J., Rivas-Lasarte M., Moustafa A.-H., Solé-González E., Paniagua-Iglesias P., Garcia-Moll X., Viladés-Medel D., Leta-Petracca R., Oristrell G., Zamora J., Ferreira-González I., Alonso-Coello P., Carreras-Costa F.. Myocardial injury after major non-cardiac surgery evaluated with advanced cardiac imaging: a pilot study. BMC Cardiovascular Disorders. 2023; 23(1)DOI:10.1186/s12872-023-03065-6. PMID:36765313. IF:2.000(Q3/6D).
11/01/2023
Cost-effectiveness of a high-sensitivity cardiac troponin T systematic screening strategy compared with usual care to identify patients with peri-operative myocardial injury after major noncardiac surgery
Popova E., Alonso-Coello P., Álvarez-García J., Paniagua-Iglesias P., Rué-Monné M., Vives-Borrás M., Font-Gual A., Gich-Saladich I., Martínez-Bru C., Ordóñez-Llanos J., Carles-Lavila M.. Cost-effectiveness of a high-sensitivity cardiac troponin T systematic screening strategy compared with usual care to identify patients with peri-operative myocardial injury after major noncardiac surgery. EUROPEAN JOURNAL OF ANAESTHESIOLOGY. 2023; 40(3)DOI:10.1097/EJA.0000000000001793. PMID:36722187. IF:4.200(Q1/2D).
01/01/2023
Quality of Life and Post-Surgical Complications in Patients on Chronic Antiplatelet Therapy with Proximal Femur Fracture: 12-Month Follow-Up after Implementing a Strategy to Shorten the Time to Surgery
Merchán-Galvis A., Anaya R., Rodriguez M., Llorca J., Castejón M., Gil J.M., Millan A., Estepa V., Cardona E., Garcia-Sanchez Y., Ruiz A., Martinez-Zapata M.J.. Quality of Life and Post-Surgical Complications in Patients on Chronic Antiplatelet Therapy with Proximal Femur Fracture: 12-Month Follow-Up after Implementing a Strategy to Shorten the Time to Surgery. Journal of Clinical Medicine. 2023; 12(3)DOI:10.3390/jcm12031130. PMID:36769778. IF:3.000(Q1/2D).
03/03/2022
High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality
Devereaux, PJ, Lamy, A, Chan, MTV, Allard, RV, Lomivorotov, VV, Landoni, G, Zheng, H, Paparella, D, McGillion, MH, Belley-Cote, EP, Parlow, JL, Underwood, MJ, Wang, CY, Dvirnik, N, Abubakirov, M, Fominskiy, E, Choi, S, Fremes, S, Monaco, F, Urrutia, G, Maestre, M, Hajjar, LA, Hillis, GS, Mills, NL, Margari, V, Mills, JD, Billing, JS, Methangkool, E, Polanczyk, CA, Sant'Anna, R, Shukevich, D, Conen, D, Kavsak, PA, McQueen, MJ, Brady, K, Spence, J, Le Manach, Y, Mian, R, Lee, SF, Bangdiwala, SI, Hussain, S, Borges, FK, Pettit, S, Vincent, J, Guyatt, GH, Yusuf, S, Alpert, JS, White, HD, Whitlock, RP. High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality. NEW ENGLAND JOURNAL OF MEDICINE. 2022; 386(9)DOI:10.1056/NEJMoa2000803. PMID:35235725. IF:158.500(Q1/1D).
31/01/2022
Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgery
Marcucci, M, Painter, TW, Conen, D, Leslie, K, Lomivorotov, VV, Sessler, D, Chan, MTV, Borges, FK, Zapata, MJM, Wang, CY, Xavier, D, Ofori, SN, Landoni, G, Efremov, S, Kleinlugtenbelt, YV, Szczeklik, W, Schmartz, D, Garg, AX, Short, TG, Wittmann, M, Meyhoff, CS, Amir, M, Torres, D, Patel, A, Duceppe, E, Ruetzler, K, Parlow, JL, Tandon, V, Wang, MK, Fleischmann, E, Polanczyk, CA, Jayaram, R, Astrakov, SV, Rao, M, VanHelder, T, Wu, WKK, Cheong, CC, Ayad, S, Abubakirov, M, Kirov, M, Bhatt, K, de Nadal, M, Likhvantsev, V, Iglesisas, PP, Aguado, HJ, McGillion, M, Lamy, A, Whitlock, RP, Roshanov, P, Stillo, D, Copland, I, Vincent, J, Balasubramanian, K, Bangdiwala, SI, Biccard, B, Kurz, A, Srinathan, S, Petit, S, Eikelboom, J, Richards, T, Gross, PL, Alfonsi, P, Guyatt, G, Belley-Cote, E, Spence, J, McIntyre, W, Yusuf, S, Devereaux, PJ. Rationale and design of the PeriOperative ISchemic Evaluation-3 (POISE-3): a randomized controlled trial evaluating tranexamic acid and a strategy to minimize hypotension in noncardiac surgery. Trials. 2022; 23(1)DOI:10.1186/s13063-021-05992-1. PMID:35101083. IF:2.500(Q3/8D).
01/01/2022
Effect of a Perioperative Hypotension-Avoidance Strategy Versus a Hypertension-Avoidance Strategy on the Risk of Acute Kidney Injury: A Clinical Research Protocol for a Substudy of the POISE-3 Randomized Clinical Trial
Garg, AX, Cuerden, M, Aguado, H, Amir, M, Belley-Cote, EP, Bhatt, K, Biccard, BM, Borges, FK, Chan, M, Conen, D, Duceppe, E, Efremov, S, Eikelboom, J, Fleischmann, E, Giovanni, L, Gross, P, Jayaram, R, Kirov, M, Kleinlugtenbelt, Y, Kurz, A, Lamy, A, Leslie, K, Likhvantsev, V, Lomivorotov, V, Marcucci, M, Martinez-Zapata, MJ, McGillion, M, McIntyre, W, Meyhoff, C, Ofori, S, Painter, T, Paniagua, P, Parikh, C, Parlow, J, Patel, A, Polanczyk, C, Richards, T, Roshanov, P, Schmartz, D, Sessler, D, Short, T, Sontrop, JM, Spence, J, Srinathan, S, Stillo, D, Szczeklik, W, Tandon, V, Torres, D, Van Helder, T, Vincent, J, Wang, CY, Wang, M, Whitlock, R, Wittmann, M, Xavier, D, Devereaux, PJ. Effect of a Perioperative Hypotension-Avoidance Strategy Versus a Hypertension-Avoidance Strategy on the Risk of Acute Kidney Injury: A Clinical Research Protocol for a Substudy of the POISE-3 Randomized Clinical Trial. Canadian Journal Of Kidney Health And Disease. 2022; 9DOI:10.1177/20543581211069225. PMID:35024154. IF:(Q/D).
01/01/2022
Early procalcitonin to predict mortality in critically ill COVID-19 patients: a multicentric cohort study
Veliziotis I., Benítez-Cano Martínez A., Ramos I., Larrañaga L., Nuñez M., Adalid I., Ferrando C., Arruti E., Minini A., Bassas E., Taccone F.S., Peluso L., Abad Motos A., Abad-Gurumeta A., Acevedo Bambaren I.A., Adalia R., Adalid Hernandez I., Aguilar G., Aguilera Cuchillo L., Agulló A.J., Agustí M., Albala Blanco M.I., Alberdi Enríquez A., Albericio Gil B., Alcon A., Alday Mlñoz E., Aldecoa C., Algar Yañez B., Aliaga J., Almuedo A., Alonso J.R., Alonso Montoiro P., Alonso Portela M., Alonso Viejo O., Álvarez Campo A., Álvarez García J.C., Álvarez Herreros C., Alvarez Pereira J., Álvarez Utrera F., De Borja Amador Penco F., Andrea R., Andrés J., Apodaka López N., Aponte Sierra A., Aracil Escoda N., Arguís M.J., Arias A., Arias M., Armero Ibañez R., Arribas Méndez D., Artaza Aparicio L., Avellanosa Esteruelas J., Aziz F., Azzam López A., Bachs Almenara F., Badía J.R., Bainac A., Baladron González V., Balaguer M., Balibrea J.M., Balust J., Balvis A.J., Barba Orejudo A., Barbeta E., Barbier Damborenea P., Bárcena Andrés E., Bardi T., Barreiro Aragunde S., Bassas Parga E., Batiste G., De Borja Bau González F., Bejarano Ramírez N., Belda I., Beltrán De Heredia S., Beltrán Martín M., Benatar Haserfaty J., Benet P., Bengoetxea U., Bergé R., Bernia Gil J.A., Berruezo Camacho A., Betolaza Weimer L., Bilbao Villas Ante I., Blanco Alcaide L., Bordell A., Borja De Lacy F., Borrat X., Borrell M., Bragulat E., Bravo R., Briones Orejliela C., Buenaventura Sanclemente G., Caballero A., Callalt Calvo A., Calvo A., Candela Á., Cara C., Carazo Cordobés J., Carbonell J.A., Carbonell Romero M., Del Mar Carbonell Soto M., Carcelen Viana A., Carmona I., Carmona Blesa A., Carmona Bonet A., Carramiñana A., Carrasco Seral C., Carreras A., José Carretero M., Casas P., Castellà M., Castelo Korro I., Castro P., Castro-Ceoane F., Catalán Fernandez M., Celorrio Reta M., Ceravalls J., Cerro Zaballos C., Chao Novo K., Claros Llamas E., Cobaleda Garcia-Bernalt C., Coca M., Coleta Orduna P., Comino O., Cortes Forero I.P., Cortes Sanchez E., Cotter Muoz L., Crespo Aliseda P.A., Crespo Gómez C., Cliadros Mendoza G., Cucciniello C., Cltesta Ruiz B., Cliñat T., De Deray C., De Diego O., De Dios Tomas E., De La Matta P., De Orte Sancho K., De Pablo Pajares M.A., De Retes M., Del Rio E., De Riva N., Deiros Garcia C., Díaz Carrasco S., Díaz Parada P., Diaz Rico I., Diaz Velasco N., Díez Remesal Y., Díez-Domínguez Á., Donoso Domínguez M., Domenech J., Domínguez B., Dorado Díaz T., Echevarría Blasco N., Elías Martín M.E., Escolano F., Escontrela B., Esclidero J., Espejo S., Espinosa C., Esquivel A., Esquiivel S., Ereñozaga A., Expósito S., Faba P., Felices Trivtno J., Fernández J., Fernández S., Fernández A., Fernández López N., Fernández Martín C., Fernández I., Fernández E., Fernanz Anton J., Ferrandis R., Ferreiro Pozuelo N., Ferrer M., Fervienza A., Figlieroa C., Font R., Forné D., Forés M.I., Forés L., Fuentes L., Gadín S., Gajate Martín L., Galán C., Galán J., Galiana M., Gallardo C., Gallego Santos C., Garutti I., García I., García C.A., García C., García D., García E., Gil Mayo D., García F., García A., García-Consuegra P., Garciaaranda S., Gea A., Gerardo L., Gestal M., Gil S., Gil Gomez L., Golska A., González C., González Cibrián C., Gonzalez Y., Gómez L., Gómez A., Gómez N., Gómez M., Grau L., Guasch E., Glienaga O., Gliereca A., Guerenabarrena M., Gutierrez R., Gutiérrez B., Guillén J., Heras E., Hernández M., Hernández G., Hernández C., Hernández S., Hernando J., Herrera J.T., Herrera López E., Higuera E., Hinojal Olmedillo B., Hurtado P., Ibáñez C., Ibarzabal A., Igeregi Basabe A., Iglesias Gallego B., Iglesias Garsabal P., Imaz Artazcoz I., Insalisti I., Isidro Lopez G., Ituarte Aspiazu I., Iturriclavero F., Jacas A., Jaramillo S., Jiménez B., Kitonsari S., Lara A., Larrañaga Altuna L., Lasuen Aguirre D., León I., Leyes P., Llau Pitarch J.V., Lloreda Herradon P., López A., López M., López T., López Miguelez M., López Ocáriz Olmos L., López Rico A., Loscos López D., Lucena De Pablo E., Magaldi M., Nuria Mane Ruiz M., Manzanero Arroyo M., Marcos Contreras S., Margarit A., Mariscal Ortega A.M., Maroño Boedo M.J., Martín N., Martín S., Martín Arroyo E., Martín Burcio S., Martin Celemin R., Martín De La Fuente A., Martín Grande A., Martín González M.C., Martin Hernandez G., Martín López J.J., Martin Serrano P., Martín Rabes C., Martín-Barreda D., Martínez J.A., Martínez Borja M., Martínez Castro N., Martínez García M., Martínez Pérez A., Martínez Ruiz A., Martínez-Castro S., Martínez-Ocon J., Martínez-Pallí G., Mas Serra A., Maseda E., Masgoret P., Mata Mena E., Matcan S., Mateos Sevillano E., Megia J., Meilan Paz M.L., Méndez Hernández R., Mendez Martínez E., Mendoza J., Mercadal J., Merino Julian I., Herrera L.M., Mira Betancur A., Rodriguez M., Mjertan A., Monedero P., Monleón López B., Montaner M., Montenegro O., Montero A., Montero Feijoo A., Montero López P., Montiel Carbajo M., Moral M.V., Morcillo Serra C., González R.M., Moreno López E., Moreno Puigdollers I., Moret Calvo A., Mosquera Rodríguez E., Mouhaffel Rivero N., Mourre Del Rio V., Moyamoradas J., Muñoz G., Muñoz J., Muñoz Martinez M.J., Muñoz Pérez L., Navarro R., Navas Moruno M., Naveiro Pan A., Nicolás J.M., Nieto Moreno A., Nieto Moreno E., Nieves Alonso J., Nozaljviateo B., Núñez M., Nuñez Mlirias M., Ojeda A., Olmos Molpeceres N., Ordiales González E., Ordoñez Recio Ó., Ormazábal Rementeria X., Ortiz Labrador G., Ortiz De Urbina Fernández P., Orts Rodriguez M., Otero A., Outeiro Rosato A., Oviedo D., Pajares Moncho A., Palomero Rodriguez M.Á., Paniagua P., Panzeri M., Pardo Pinzon L., Parise Roux D., Pardo M., Parrado Lopez D., Patiño Abarca A., Patiño Rodriguez E., Paz Martínez M., Peiró A., Pelegrina López M., Peralta Álvarez C., Perdomo J., Pereira Torres L., Pérez Artacho Cortés J., Pérez Blanco I., Pérez M., Pérez Larrañaga M., Pérez S., Pérez-Asenjo J., Pérez-Ferrer A., Pestaña Lagunas D., Pi Peña A., Pinto Corraliza J.M., Planas Roca A., Poch E., Polo Martín S., Pradal Jarne L., Prieto Molano L., Prieto Rodrigo M., Pujol M., Pujol R., Pluol Rosa E., Quecedo Glitierrez L., Quintana E., Rama Maceiras P., Ramasco F., Ramil E., Ramis B., Ramos J., Ramos Delgado I., Rauer Alcover F., Recasens A., Redondo Calvo F.J., Reverter E., Rey Carlín R., Rey Vázquez S., Ripolles Melchor J., Risco R., Rivas E., Rodriguez V., Rodriguez Cuesta D., Rodriguez Diaz-Regaño I., Rodriguez Esteban D., Rodriguez García C., Rojas Pernia V., Rojo Polo A., Rojo Rodriguez E., Román Guerrero C., Román L., Rovira I., Romero Fernandez A., Ruano Sliarez C., Ruanova Seijo D., Rubio Baines I., Ruigómez Saiz Á., Ruiz A., Ruiz Bocos A., Ruiz Escobar A., Ruiz P., Saavedra Villarino B., Sagra J., Sáez Ruiz E., Sainz Mandiola I., Sala Trull C., Samaranch Palero N., Sanabraloewe M., Sanahuja P., Sánchez Campos A., Sánchez Martín C., Sánchez-Etayo G., Sandoval E., Cruz Hernando A.S., Santidrián Bernal S.O., Santos Pérez G., Sanz González R., Sarmiento-Trujillo T., Schneider S., Serna Pérez J., Serra Pujol P., Serra Valls M., Serrallonga Castells A., Serrano J., Serrano Romero A.B., Sibila O., Smith Vielma L.G., Solé C., Soria Lozano M., Soriano A., Souto Higueras J., Soy D., Stolle Dlieñas D., Suárez M., Suárez de la Rica A., Tallo Forga M., Tamayo Medel G., Tatjer I., Tejedor Navarro A., Téllez A., Tena B., Tercero López J., Tirado Errazquin A., Tiscar García C., Toapanta N.D., Tomás Ortiz J., de la Torre Concostrina M., Torrente Pérez J., Torres A., Torres T., Ubré M., Unigarro F., Ureta Mesa E.M., Urra X., Urrutia Izagirre E., Urutxurtli Laureano E., Valenzuela Peña M., Vallejo Lantero C., Vallinas Hidalgo I., Varela M., Vázquez Lima A., Vázquez Rivero B., Veganzones J., Velasco Olarte E., Vendrell M., Vicente R., Vicente Orgaz M., Vicol A., Vidal A., Vilches Garcia A., Villahoz Martinez J., Villalaba Palacios R., Villanueva García G., Villazala González R., Vogel de Medeiros C., Yagüe J., Zabal Maeztu A., Zattera L., Zubizarreta I.. Early procalcitonin to predict mortality in critically ill COVID-19 patients: a multicentric cohort study. Minerva Anestesiologica. 2022; 88(4)DOI:10.23736/s0375-9393.22.15942-0. PMID:35072432. IF:3.200(Q2/5D).
01/01/2022
Propofol sedation administered by cardiologists in echocardiography studies
Li C.-H., González-Salvado V., Bertolí E., Viladés D., Descalzo M., Carreras F., Leta R., Cinca J., Capellades H., Cueva L., Paniagua P.. Propofol sedation administered by cardiologists in echocardiography studies. Rec: Cardioclinics. 2022; 57(1)DOI:10.1016/j.rccl.2021.02.007. PMID:. IF:(Q/D).
01/12/2021
SEDAR/SECCE ECMO management consensus document
Zarragoikoetxea, I, Pajares, A, Moreno, I, Porta, J, Koller, T, Cegarra, V, Gonzalez, AI, Eiras, M, Sandoval, E, Sarralde, JA, Quintana-Villamandos, B, Guillen, RV. SEDAR/SECCE ECMO management consensus document. Cirugia Cardiovascular. 2021; 28(6)DOI:10.1016/j.circv.2021.06.006. PMID:. IF:(Q/D).
01/12/2021
EPIdemiology of Surgery-Associated Acute Kidney Injury (EPIS-AKI): study protocol for a multicentre, observational trial
Weiss, R, Saadat-Gilani, K, Kerschke, L, Wempe, C, Meersch, M, Zarbock, A, Batalla A., EPIS-AKI Investigators. EPIdemiology of Surgery-Associated Acute Kidney Injury (EPIS-AKI): study protocol for a multicentre, observational trial. BMJ Open. 2021; 11(12)DOI:10.1136/bmjopen-2021-055705. PMID:35588372. IF:3.007(Q2/5D).
18/11/2021
Early Surgery with Neuraxial Anaesthesia in Patients on Chronic Antiplatelet Therapy with a Proximal Femur Fracture: Multicentric Randomised Clinical Trial
Anaya, R, Rodriguez, M, Millan, A, Reguant, F, Llorca, J, Guilabert, P, Ruiz, A, Pantoja, PE, Gil, JM, Moral, V, Merchan-Galvis, A, Martinez-Zapata, MJ. Early Surgery with Neuraxial Anaesthesia in Patients on Chronic Antiplatelet Therapy with a Proximal Femur Fracture: Multicentric Randomised Clinical Trial. Journal of Clinical Medicine. 2021; 10(22)DOI:10.3390/jcm10225371. PMID:34830654. IF:4.964(Q2/4D).
01/10/2021
Persistent Incisional Pain after Noncardiac Surgery: An International Prospective Cohort Study
Khan, JS, Sessler, DI, Chan, MTV, Wang, CY, Garutti, I, Szczeklik, W, Turan, A, Busse, JW, Buckley, DN, Paul, J, McGillion, M, Fernandez-Riveira, C, Srinathan, SK, Shanthanna, H, Gilron, I, Jacka, M, Jackson, P, Hankinson, J, Paniagua, P, Pettit, S, Devereaux, PJ. Persistent Incisional Pain after Noncardiac Surgery: An International Prospective Cohort Study. ANESTHESIOLOGY. 2021; 135(4)DOI:10.1097/ALN.0000000000003951. PMID:34499129. IF:9.198(Q1/2D).
01/10/2021
SEDAR/SECCE ECMO management consensus document
Zarragoikoetxea, I, Pajares, A, Moreno, I, Porta, J, Koller, T, Cegarra, V, Gonzalez, AI, Eiras, M, Sandoval, E, Sarralde, JA, Quintana-Villamandos, B, Guillen, RV. SEDAR/SECCE ECMO management consensus document. Revista Espanola De Anestesiologia Y Reanimacion. 2021; 68(8)DOI:10.1016/j.redar.2020.12.011. PMID:34246486. IF:(Q/D).
01/08/2021
Prevention of Cardiac Surgery-Associated Acute Kidney Injury by Implementing the KDIGO Guidelines in High-Risk Patients Identified by Biomarkers: The PrevAKI-Multicenter Randomized Controlled Trial
Zarbock, A, Kullmar, M, Ostermann, M, Lucchese, G, Baig, K, Cennamo, A, Rajani, R, McCorkell, S, Arndt, C, Wulf, H, Irqsusi, M, Monaco, F, Di Prima, AL, Alvarez, MG, Italiano, S, Bagan, JM, Kunst, G, Nair, S, L'Acqua, C, Hoste, E, Vandenberghe, W, Honore, PM, Kellum, JA, Forni, LG, Grieshaber, P, Massoth, C, Weiss, R, Gerss, J, Wempe, C, Meersch, M. Prevention of Cardiac Surgery-Associated Acute Kidney Injury by Implementing the KDIGO Guidelines in High-Risk Patients Identified by Biomarkers: The PrevAKI-Multicenter Randomized Controlled Trial. ANESTHESIA AND ANALGESIA. 2021; 133(2)DOI:10.1213/ANE.0000000000005458. PMID:33684086. IF:6.627(Q1/3D).
01/11/2025
Enhanced recovery after surgery and long-term oncologic outcomes: Post-hoc analysis of the POWER study
Ripollés-Melchor, J, Zorrilla-Vaca, A, Leon-Bretscher, A, Abad-Motos, A, Galán-Menéndez, P, Muñoz-Rodés, JL, Zapata, D, Ramiro-Ruiz, A, Aldecoa, C, Molnar, V, Jordá-Sanz, L, Cuéllar-Martinez, A, Berges-Gutiérrez, H, Landaluce-Olavarria, A, Fernández-Garcia, R, Aracil-Escoda, N, Pacual-Bellosta, AM, Ubré-Lorenzo, M, Logroño-Ejea, M, Romero, ABS, Soriano-Giménez, V, Romero-Marcos, JM, Nogués-Ramia, E, Mugarra-Llopis, A, Sánchez-Navas, S, Serrat-Puyol, J, Orts-Mico, FJ, Llácer-Pérez, M, Gil-Trujillo, S, Alday-Muñoz, E, Calero-Lillo, A, Gimeno-Fernández, P, Sánchez-Martin, R, Bustos-Garcia, D, Batalla-González, A, Chornet, MR, Rodriguez-Jiménez, R, Antona, JF, Jerico-Alba, C, Pedregosa-Sanz, A, Navarro-Sánchez, A, Viñas-Martinez, T, Erce, JAG, Oriol, MP, Abad-Gurumeta, A. Enhanced recovery after surgery and long-term oncologic outcomes: Post-hoc analysis of the POWER study. Revista Espanola De Anestesiologia Y Reanimacion. 2025; 72(9)DOI:10.1016/j.redar.2025.501926. PMID:40912546. IF:(Q/D).
01/08/2025
Hemodynamic support Prospective multicenter observational study of patients in shock treated with vasopressin: Protocol of the VASOPRESIN with vasopressin: VASOPRES Registry study protocol
Alvarez, RG, Ramasco, F, Alonso, JN, Mouriz, L, Rama, P, Bilbao, I, Carbonell, AP, Rodenas, MA, Ortega, F, Vives, M, Calvo, CA, Taboada, M, Azzam, A, Merino, M, Martinez, F, Dominguez, D, de Llano, CT, Adalia, R, Aguilar, G, Aldecoa, C, Mancha, B, Reyes, A, Giné, M, Prendes, D, Fernández, CG, de la Calle, I, Cendrero, M, López, AM, Herrero, JJ, de la Torre, I, Kattan, E, Hernández, G. Hemodynamic support Prospective multicenter observational study of patients in shock treated with vasopressin: Protocol of the VASOPRESIN with vasopressin: VASOPRES Registry study protocol. Revista Espanola De Anestesiologia Y Reanimacion. 2025; 72(7)DOI:10.1016/j.redar.2025.501768. PMID:. IF:(Q/D).
30/06/2025
Improving the Compliance of Massive Hemorrhage Protocols Through Education Is Associated with Patient Survival
Paniagua-Iglesias, P, Rincón-Ferrari, MD, Candela-Toha, A, Marcos-Jubilar, M, Barquero-Lopez, M, Gich-Saladich, I, Medina-Marrero, L, Bosch-Llobet, A, Garrido-Fleischmann, D, Ordoñez-Llanos, J, Urrutia-Cuchí, G. Improving the Compliance of Massive Hemorrhage Protocols Through Education Is Associated with Patient Survival. Journal of Clinical Medicine. 2025; 14(13)DOI:10.3390/jcm14134632. PMID:40649007. IF:2.900(Q1/2D).
01/02/2025
The Potential Role of Albumin in Reducing Cardiac Surgery-Associated Acute Kidney Injury: A Randomized Controlled Trial
Bagán, JM, Quiles, LP, Iglesias, PP, Roig, AJB, Tenas, SS, García, SP, Alvarez, MG. The Potential Role of Albumin in Reducing Cardiac Surgery-Associated Acute Kidney Injury: A Randomized Controlled Trial. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA. 2025; 39(2)DOI:10.1053/j.jvca.2024.10.012. PMID:39922683. IF:2.100(Q2/4D).
20/01/2025
Economic evaluation of a strategy to shorten the time to surgery with neuraxial anaesthesia compared with usual clinical practice in patients on chronic antiplatelet therapy with a proximal femur fracture
Delgado-Espinoza, CE, Antonijoan, RM, Gich, I, Anaya, R, Rodriguez, M, Millan, A, Llorca, J, Usua, G, Ruiz, A, Merchán-Galvis, A, Martinez-Zapata, MJ, AFFEcT Study Grp. Economic evaluation of a strategy to shorten the time to surgery with neuraxial anaesthesia compared with usual clinical practice in patients on chronic antiplatelet therapy with a proximal femur fracture. Frontiers In Health Services. 2025; 4DOI:10.3389/frhs.2024.1423975. PMID:39901976. IF:(Q/D).